Algo version: 0.98b
BioNTech SE is listed at the XETRA Exchange
BioNTech SE [22UA.F]
XETRA Sector: Healthcare Industry:Biotechnology

Is BioNTech SE stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, BioNTech SE pays dividends. Last time was Friday 17th of June 2022 where the investors holding the stock on Thursday 2nd of June 2022 were paid €2.111 per share. Over the last 1 times between 2022 and 2022, BioNTech SE has paid €2.111 with an average of €2.11 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for BioNTech SE 10 years ago, but if you had invested on Friday 11th of October 2019 when the price was €12.97, you would have made a profit of €67.48 per share or 520.28%

No, the average daily trading liquidity for BioNTech SE is €848 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

BioNTech SE has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 24.22, the company's ability to pay off the debt is good. The company has a very low net profit margin of 4.07%, which is challenging.

We have calculated the inflation risk for BioNTech SE to be low [0.2 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.